MCGLYNN MARGARET G
SEC CIK 1215126 · EDGAR
BoughtSold
Most active insiders at NVAX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Draghia-Akli Ruxandra | Section 16 | — | — |
| 2 | O'Hara Elaine | EVP, Chief Strategy Off | — | — |
| 3 | Shiver John W. | Dir | — | — |
| 4 | Newton Charles W. | Dir | — | — |
| 5 | Jacobs John C | Pres, CEO, Dir | — | — |
| 6 | King Rachel K. | Dir | — | — |
| 7 | Kelly James Patrick | EVP, CFO, Treas | — | — |
| 8 | Casey Mark J | EVP, CLO | — | — |
| 9 | Alton Gregg H | Dir | — | — |
| 10 | Rodgers Richard J | Dir | — | — |
| 12 | MCGLYNN MARGARET G | Dir | — | — |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-23 19:55 | 2026-06-20 | NVAX | NOVAVAX INC | MCGLYNN MARGARET G | Dir | M - OptEx | — | +18.9K | 44.5K | +74% | — |
| D | 2025-06-16 | 2025-06-12 | NVAX | NOVAVAX INC | MCGLYNN MARGARET G | Dir | M - OptEx | $0.00 | +10.4K | 25.6K | +69% | $0 |
| M | 2025-02-05 | 2024-03-31+ | NVAX | NOVAVAX INC | MCGLYNN MARGARET G | Dir | A - Grant | $8.50 | +4,698 | 13.2K | +55% | +$40.0K |
| D | 2024-06-14 | 2024-06-12 | NVAX | NOVAVAX INC | MCGLYNN MARGARET G | Dir | M - OptEx | $0.00 | +6,670 | 10.5K | +176% | $0 |
| D | 2023-06-13 | 2023-06-10 | NVAX | NOVAVAX INC | MCGLYNN MARGARET G | Dir | M - OptEx | — | +3,100 | 3,800 | +443% | — |
| D | 2022-06-21 | 2022-06-17 | NVAX | NOVAVAX INC | MCGLYNN MARGARET G | Dir | M - OptEx | — | +700 | 700 | New | — |
| D | 2022-05-03 | 2022-05-01 | VRTX | Vertex Pharmaceuticals | MCGLYNN MARGARET G | Dir | D - Sale to Iss | — | -921 | 178 | -84% | — |
| DM | 2022-04-12 | 2022-04-08 | VRTX | Vertex Pharmaceuticals | MCGLYNN MARGARET G | Dir | S - Sale+OE | $280.22 | -5,000 | 1,099 | -82% | -$1.40M |
| D | 2022-04-12 | 2022-04-08 | VRTX | Vertex Pharmaceuticals | MCGLYNN MARGARET G | Dir | M - OptEx | $127.54 | +5,000 | 6,099 | +455% | +$637.7K |
| D | 2022-04-04 | 2022-03-31 | VRTX | Vertex Pharmaceuticals | MCGLYNN MARGARET G | Dir | M - OptEx | $127.54 | +5,000 | 6,099 | +455% | +$637.7K |
| DM | 2022-04-04 | 2022-03-31 | VRTX | Vertex Pharmaceuticals | MCGLYNN MARGARET G | Dir | S - Sale+OE | $262.27 | -5,000 | 5,080 | -50% | -$1.31M |
| DM | 2022-02-01 | 2022-01-28 | VRTX | Vertex Pharmaceuticals | MCGLYNN MARGARET G | Dir | S - Sale+OE | $241.79 | -5,000 | 4,198 | -54% | -$1.21M |
| D | 2022-02-01 | 2022-01-28 | VRTX | Vertex Pharmaceuticals | MCGLYNN MARGARET G | Dir | M - OptEx | $127.54 | +5,000 | 6,099 | +455% | +$637.7K |
Purchase Sale Sale after option exercise All abbreviations